| P2093 | author name string | M J Alcaraz | |
| | M Payá | |
| | S De Rosa | |
| | A De Giulio | |
| | P García Pastor | |
| P2860 | cites work | NKR-P1A stimulation of arachidonate-generating enzymes in rat NK cells is associated with granule release and cytotoxic activity | Q73453121 |
| | Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF-alpha in lipopolysaccharide-induced type II phospholipase A2 synthesis | Q73453149 |
| | Group II phospholipase A2 is increased in peritoneal and pleural effusions in patients with various types of cancer | Q73507923 |
| | Segregated coupling of phospholipases A2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages | Q74336632 |
| | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| | 5-Lipoxygenase Products Modulate the Activity of the 85-kDa Phospholipase A2 in Human Neutrophils | Q28291918 |
| | Novel group V phospholipase A2 involved in arachidonic acid mobilization in murine P388D1 macrophages | Q28511451 |
| | PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines | Q29620217 |
| | Gene expression of group II phospholipase A2 in intestine in ulcerative colitis | Q33617702 |
| | Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. | Q33826817 |
| | Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells | Q33908899 |
| | Inhibition of calcium-independent phospholipase A2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages | Q33989590 |
| | Bactericidal properties of murine intestinal phospholipase A2. | Q34200767 |
| | Phospholipase A2 Inhibitors from Marine Organisms | Q35208714 |
| | Posttranscriptional effect of insulin-like growth factor-I on interleukin-1beta-induced type II-secreted phospholipase A2 gene expression in rabbit articular chondrocytes | Q37365835 |
| | Depletion of human monocyte 85-kDa phospholipase A2 does not alter leukotriene formation | Q38349384 |
| | The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. | Q39759518 |
| | Phospholipase A2 and arthritis | Q40874634 |
| | Lipid mediator networks in cell signaling: update and impact of cytokines. | Q41073474 |
| | Antisense inhibition of 85-kDa cPLA2 blocks arachidonic acid release from airway epithelial cells | Q41096590 |
| | Minimal oxidation and storage of low density lipoproteins result in an increased susceptibility to phospholipid hydrolysis by phospholipase A2. | Q41098668 |
| | Suppression of cytokine synthesis, integrin expression and chronic inflammation by inhibitors of cytosolic phospholipase A2. | Q41109613 |
| | The growing phospholipase A2 superfamily of signal transduction enzymes | Q41341078 |
| | Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. | Q41461839 |
| | Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids | Q41566551 |
| | Lysophospholipases I and II from P388D1 macrophage-like cell line | Q41700729 |
| | Characterization of nitric oxide synthases in non-adrenergic non-cholinergic nerve containing tissue from the rat anococcygeus muscle | Q41857240 |
| | Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation | Q41957754 |
| | Stimulation of Ca2+-activated human platelet phospholipase A2 by diacylglycerol | Q41987642 |
| | Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat | Q42027334 |
| | Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation. | Q42191689 |
| | Development of a novel, Ins(1,4,5)P3-specific binding assay. Its use to determine the intracellular concentration of Ins(1,4,5)P3 in unstimulated and vasopressin-stimulated rat hepatocytes | Q42496597 |
| | Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo | Q42543352 |
| | Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents | Q44312395 |
| | Inactivation of human synovial fluid phospholipase A2 by the marine natural product, manoalide | Q44696722 |
| | Distinct roles in signal transduction for each of the phospholipase A2 enzymes present in P388D1 macrophages. | Q44816682 |
| | Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid | Q45076745 |
| | Characterization of phospholipase A2 release by elicited-peritoneal macrophage and its relationship to eicosanoid production. | Q46756569 |
| | Interleukin-1 beta induces cytosolic phospholipase A2 and prostaglandin H synthase in rheumatoid synovial fibroblasts. Evidence for their roles in the production of prostaglandin E2. | Q47562335 |
| | Phospholipid metabolism by phagocytic cells. Phospholipases A2 associated with rabbit polymorphonuclear leukocyte granules. | Q53750553 |
| | Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes. | Q54625648 |
| | Augmentation of prostaglandin E2 production by mammalian phospholipase A2 added exogenously | Q67802873 |
| | Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle | Q67803548 |
| | Adjuvant arthritis | Q68032195 |
| | Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids | Q69931802 |
| | Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents | Q69982592 |
| | Leukotrienes augment interleukin 1 production by human monocytes | Q70110226 |
| | The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system | Q70161398 |
| | Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type II phospholipases A2 | Q70527465 |
| | Anti-inflammatory testing methods: Comparative evaluation of mice and rats | Q70978327 |
| | Cacospongionolide B, a new sesterterpene from the sponge Fasciospongia cavernosa | Q70984324 |
| | Differential effects of tenidap on the zymosan- and lipopolysaccharide-induced expression of mRNA for proinflammatory cytokines in macrophages | Q71183947 |
| | Human type II phospholipase A2-induced Mac-1 expression on human neutrophils | Q71444414 |
| | Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation | Q71556848 |
| | Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase | Q71691391 |
| | Effect of thielocin A1 beta on bee venom phospholipase A2-induced edema in mouse paw | Q71735608 |
| | Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDS and Cox 2 inhibitors | Q71799101 |
| | A study of the novel anti-inflammatory agent florifenine topical anti-inflammatory activity and influence on arachidonic acid metabolism and neutrophil functions | Q71874374 |
| | Regulation of tumor necrosis factor-alpha and IL-1 beta synthesis by thromboxane A2 in nonadherent human monocytes | Q71929959 |
| | Lipocortin-1 and the control of arachidonic acid release in cell signalling. Glucocorticoids (changed from glucorticoids) inhibit G protein-dependent activation of cPLA2 activity | Q71987537 |
| | Exogenous group II phospholipase A2 induces prostaglandin E2 production in mouse peritoneal macrophages | Q72020194 |
| | Protein kinase C-dependent and -independent pathways of mitogen-activated protein kinase activation in macrophages by stimuli that activate phospholipase A2 | Q72068791 |
| | Recombinant secreted nonpancreatic phospholipase A2 induces a synovitis-like inflammation in the rat air pouch | Q72137796 |
| | Differential regulation of elicited-peritoneal macrophage 14 kDa and 85 kDa phospholipase A2(s) by transforming growth factor-beta | Q72277786 |
| | Evidence that secretory phospholipase A2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells | Q72432610 |
| | Tight binding inhibitors of 85-kDa phospholipase A2 but not 14-kDa phospholipase A2 inhibit release of free arachidonate in thrombin-stimulated human platelets | Q72466009 |
| | Regulation of CD11b/CD18 expression in human neutrophils by phospholipase A2 | Q72574721 |
| | CGP 47969A: effect on collagen induced arthritis in DBA/1 mice | Q72576054 |
| | Macrophage arachidonate release via both the cytosolic Ca(2+)-dependent and -independent phospholipases is necessary for cell spreading | Q73066778 |
| | Activation of cytosolic phospholipase A2 by platelet-derived growth factor is essential for cyclooxygenase-2-dependent prostaglandin E2 synthesis in mouse osteoblasts cultured with interleukin-1 | Q73084769 |
| | Group II phospholipase A2 as an autocrine growth factor mediating interleukin-1 action on mesangial cells | Q73185499 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 301-311 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2 | |
| P478 | volume | 126 | |